Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$33.11 - $55.01 $5,794 - $9,626
-175 Closed
0 $0
Q4 2020

Feb 03, 2021

BUY
$79.17 - $111.47 $11,875 - $16,720
150 Added 600.0%
175 $16,000
Q3 2020

Nov 09, 2020

BUY
$81.91 - $134.94 $2,047 - $3,373
25 New
25 $3,000
Q2 2019

Aug 01, 2019

SELL
$39.92 - $53.86 $13,972 - $18,851
-350 Closed
0 $0
Q1 2019

May 06, 2019

BUY
$48.23 - $66.16 $16,880 - $23,156
350 New
350 $18,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $232M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Sandy Spring Bank Portfolio

Follow Sandy Spring Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.